These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8619518)

  • 81. [Ganglionopathies: evolving concept and ideas on management].
    Kuntzer T
    Rev Neurol (Paris); 2006 Dec; 162(12):1268-72. PubMed ID: 17151522
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Role of immunologic disorders in the etiology of colitis].
    Levitan MKh; Shadrin BP; Khalif IL
    Ter Arkh; 1982; 54(2):144-7. PubMed ID: 7041316
    [No Abstract]   [Full Text] [Related]  

  • 83. [Paraneoplastic and disimmune sensory neuronopathies or ganglionopathies. Importance of an early detection].
    Urdiales-Urdiales J; Tejada-García J; Urdiales-Sánchez S; Hernández-Rodríguez J; Soto-García J; Piquero-Fernández J
    Rev Neurol; 2019 Dec; 69(11):435-441. PubMed ID: 31761998
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Some speculations on the origins of autoantibodies.
    Schwartz RS
    Ann N Y Acad Sci; 1987; 505():8-11. PubMed ID: 3479942
    [No Abstract]   [Full Text] [Related]  

  • 85. Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis.
    Kurtis MM; Toledano R; García-Morales I; Gil-Nagel A
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1286-7. PubMed ID: 26320889
    [No Abstract]   [Full Text] [Related]  

  • 86. Glycolipids in acoustic neurinoma.
    Handa S; Ikeda A; Komatsuzaki A; Taki T
    Ann N Y Acad Sci; 1998 Jun; 845():411. PubMed ID: 9668380
    [No Abstract]   [Full Text] [Related]  

  • 87. Gangliosides and peripheral neuropathies: an overview.
    Asbury AK
    Prog Brain Res; 1994; 101():279-87. PubMed ID: 8029456
    [No Abstract]   [Full Text] [Related]  

  • 88. Autoimmune-mediated peripheral neuropathies and autoimmune pain.
    Klein CJ
    Handb Clin Neurol; 2016; 133():417-46. PubMed ID: 27112690
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; 2) Pathogenesis and treatment of immune-mediated neuropathies; the cutting edge].
    Kusunoki S
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2105-10. PubMed ID: 27522759
    [No Abstract]   [Full Text] [Related]  

  • 90. Neuromyotonia: a new autoimmune disease.
    Layzer RB
    Ann Neurol; 1995 Nov; 38(5):701-2. PubMed ID: 7486859
    [No Abstract]   [Full Text] [Related]  

  • 91. Enzymes as autoantigens.
    Lancet; 1992 Mar; 339(8796):779-80. PubMed ID: 1347806
    [No Abstract]   [Full Text] [Related]  

  • 92. Autoimmune responses in peripheral nerve.
    Hartung HP; Willison H; Jung S; Pette M; Toyka KV; Giegerich G
    Springer Semin Immunopathol; 1996; 18(1):97-123. PubMed ID: 8984683
    [No Abstract]   [Full Text] [Related]  

  • 93. [How to Perform Autoantibody Testing for Autoimmune and Inflammatory Diseases of Peripheral Nerves and Muscles].
    Koga M
    Brain Nerve; 2024 May; 76(5):443-448. PubMed ID: 38741482
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A-specific autoantigenic ovarian glycolipids inducing production of 'natural' anti-A antibody.
    Arend P; Nijssen J
    Nature; 1977 Sep; 269(5625):255-7. PubMed ID: 563514
    [No Abstract]   [Full Text] [Related]  

  • 95. Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies.
    Bertran Recasens B; Figueras-Aguirre G; Royo De Mingo I; Rubio MÁ
    Neurologia (Engl Ed); 2021; 36(9):739-742. PubMed ID: 34266798
    [No Abstract]   [Full Text] [Related]  

  • 96. Immunological investigation.
    O'Leary C; Willison HJ
    Curr Opin Neurol; 1995 Oct; 8(5):349-53. PubMed ID: 8542038
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical Problems.
    Bibas M; Sarosiek S; Castillo JJ
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024061. PubMed ID: 38984103
    [TBL] [Abstract][Full Text] [Related]  

  • 98. SARS-CoV-2 Attacks in the Brain: Focus on the Sialome.
    Wielgat P; Narejko K; Car H
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563764
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation.
    Seixas MLGA; Mitre LP; Shams S; Lanzuolo GB; Bartolomeo CS; Silva EA; Prado CM; Ureshino R; Stilhano RS
    Front Nutr; 2022; 9():825629. PubMed ID: 35223956
    [TBL] [Abstract][Full Text] [Related]  

  • 100. SARS-CoV-2 involvement in central nervous system tissue damage.
    Haidar MA; Shakkour Z; Reslan MA; Al-Haj N; Chamoun P; Habashy K; Kaafarani H; Shahjouei S; Farran SH; Shaito A; Saba ES; Badran B; Sabra M; Kobeissy F; Bizri M
    Neural Regen Res; 2022 Jun; 17(6):1228-1239. PubMed ID: 34782556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.